1. Home
  2. MPTI vs AKBA Comparison

MPTI vs AKBA Comparison

Compare MPTI & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M-tron Industries Inc.

MPTI

M-tron Industries Inc.

HOLD

Current Price

$72.60

Market Cap

350.9M

Sector

N/A

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.20

Market Cap

375.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPTI
AKBA
Founded
1965
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
350.9M
375.0M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
MPTI
AKBA
Price
$72.60
$1.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$71.00
$4.67
AVG Volume (30 Days)
62.7K
2.9M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
93.94
EPS
2.62
N/A
Revenue
$54,417,000.00
N/A
Revenue This Year
$11.06
N/A
Revenue Next Year
$12.15
N/A
P/E Ratio
$29.41
N/A
Revenue Growth
11.03
N/A
52 Week Low
$36.38
$1.13
52 Week High
$87.23
$4.08

Technical Indicators

Market Signals
Indicator
MPTI
AKBA
Relative Strength Index (RSI) 56.80 37.84
Support Level $60.13 $1.16
Resistance Level $79.58 $1.56
Average True Range (ATR) 4.06 0.07
MACD 1.23 -0.03
Stochastic Oscillator 50.16 18.07

Price Performance

Historical Comparison
MPTI
AKBA

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is an electronic components manufacturer based in the United States. Along with its subsidiaries, the company is engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company serves markets in aerospace and defense, space, and avionics sectors. Its product offerings include microwave and millimeter-wave filters, crystal resonators, clock oscillators, voltage-controlled crystal oscillators, low noise amplifiers, couplers, attenuators, and switches, among others. Geographically, it derives maximum revenue from the domestic market, and the rest from Malaysia, Australia, Greece, and other countries.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: